| AOP | Adverse Outcome Pathway |
| CI | Confidence interval |
| CKD | Chronic kidney disease |
| CyanoHAB | Cyanobacterial harmful algal bloom |
| ELISA | Enzyme-linked immunosorbent assay |
| HCC | Hepatocellular carcinoma |
| LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| MC | Microcystin |
| OATP | Organic anion-transporting polypeptide |
| OR | Odds ratio |
| PECO | Population-Exposure-Comparator-Outcome |
| PP1/PP2A | Protein phosphatases 1 and 2A |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| RoB | Risk of bias |